The novelty of our study is the measurement of six tumour biomarkers in a well‐defined sizeable cohort (BIOSTAT‐CHF), in which CA125, CYFRA 21‐1, CEA and CA19‐9 provided equivalent predictive value with NT‐proBNP for clinical HF outcomes. This evidence concerns the gene NPPB and neoplasm.